
A Peptide Approach to Reducing alpha-Synuclein in Parkinson's Disease
04-12-2021 / Learn about a new approach to the treatment of Parkinson's disease alpha-synuclein pathology that uses a cell-penetrating peptide to induce proteasome degradation of alpha-synuclein.
Read More